MedTrace Logo

Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma

NCT02761252 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 454

Last updated 2019-07-12

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare concomitant administration of Montelukast and Bilastine to Montelukast and Bilastine monotherapies in patients with SARC and asthma

Conditions

  • Seasonal Allergic Rhinoconjunctivitis
  • Asthma

Interventions

DRUG

Bilastine 20mg

DRUG

Montelukast 10mg

DRUG

Placebo Bilastine 20mg

DRUG

Placebo Montelukast 10mg

Sponsors & Collaborators

  • Menarini International Operations Luxembourg SA

    lead INDUSTRY

Principal Investigators

  • Massimo Pistolesi, Prof · AOUC Azienda Ospedaliero-Universitaria Careggi

  • Oliviero Rossi, Prof · AOUC Azienda Ospedaliero-Universitaria Careggi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-13
Primary Completion
2016-11-24
Completion
2016-11-24

Countries

  • Croatia
  • Czechia
  • Germany
  • Italy
  • Latvia
  • Poland
  • Romania
  • Slovakia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02761252 on ClinicalTrials.gov